Pfizer, Novartis Lead Pharma Spending Spree on Gene Therapy Production Pfizer, Novartis Lead Pharma Spending Spree on Gene Therapy Production

Eleven drugmakers led by Pfizer and Novartis have set aside a combined $2 billion to invest in gene therapy manufacturing since 2018, according to a Reuters analysis, in a drive to better control production of the world ' s priciest medicines.Reuters Health Information
Source: Medscape Pathology Headlines - Category: Pathology Tags: Internal Medicine News Source Type: news